213. Effect of Interventions Aimed at Reducing or Modifying Saturated Fat Intake on Cholesterol, Mortality, and Major Cardiovascular Events : A Risk Stratified Systematic Review of Randomized Trials.
作者: Jeremy P Steen.;Kevin C Klatt.;Yaping Chang.;Gordon H Guyatt.;Hongfei Zhu.;Mateusz J Swierz.;Dawid Storman.;Mingyao Sun.;Yunli Zhao.;Long Ge.;Lehana Thabane.;Nirjhar R Ghosh.;Giorgio Karam.;Pablo Alonso-Coello.;Malgorzata M Bala.;Bradley C Johnston.
来源: Ann Intern Med. 2026年179卷2期242-255页
Debates about optimal saturated fat advice continue.
214. Efficacy and Safety of Bisphosphonates for Complex Regional Pain Syndrome : A Systematic Review and Meta-analysis.
作者: Michael C Ferraro.;Neil E O'Connell.;Andreas Goebel.;Ruaraidh Hill.;Ffion Curtis.;Jack Wilkinson.;Jacqueline R Center.;Sylvia M Gustin.;Aidan G Cashin.;James H McAuley.
来源: Ann Intern Med. 2026年179卷2期256-269页
Clinical guidelines recommend bisphosphonates for complex regional pain syndrome (CRPS) despite limited evidence of efficacy.
216. Diagnostic Follow-up of Positive Results on Low-Dose Computed Tomography Screening in the Medicare Population.
作者: Paul F Pinsky.;Gerard Silvestri.;Raymond Osarogiagbon.;Farhood Farjah.;Eric Miller.;Ella Kazerooni.;Lindsey Enewold.;Louise Henderson.;Danielle Durham.;Robert A Smith.;Philip Connor.;Andrew Ward.;Paul Doria-Rose.
来源: Ann Intern Med. 2026年179卷2期187-195页
Diagnostic evaluation of positive screening results for lung cancer is critically important for optimal outcomes. Data on such follow-up are limited.
217. Eligibility and Prognostic Performance of Smoking Duration-Based Versus Pack-Year-Based U.S. National Lung Cancer Screening Criteria Across Racial and Ethnic Groups.
作者: Chloe C Su.;Victoria Y Ding.;Kevin Ten Haaf.;Julie T Wu.;Neal D Freedman.;Leah M Backhus.;Ann N Leung.;Natalie S Lui.;Christopher A Haiman.;Sung-Shim Lani Park.;Joel W Neal.;Rafael Meza.;Martin C Tammemägi.;Iona Cheng.;Loïc Le Marchand.;Heather A Wakelee.;Eunji Choi.;Summer S Han.
来源: Ann Intern Med. 2026年179卷2期196-206页
The U.S. Preventive Services Task Force expanded lung cancer (LC) screening eligibility in 2021 (USPSTF-2021) by decreasing the minimum number of smoking pack-years from 30 to 20. Underrepresented minorities still experience disparities in screening eligibility.
|